HTRA4
Serine protease HTRA4
Also known as: FLJ90724, HTRA4_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P83105
- Gene
- HTRA4
- Ensembl
- ENSG00000169495
- Chromosome
- 8
- Canonical length
- 476 aa
- Protein class
- Enzymes, Predicted secreted proteins
- Secretome location
- Secreted in female reproductive system
OverviewNCBI Gene
This gene encodes a member of the HtrA family of proteases. The encoded protein contains a putative signal peptide, an insulin growth factor binding domain, a Kazal protease inhibitor domain, a conserved trypsin domain and a PDZ domain. Based on studies on other related family members, this enzyme may function as a secreted oligomeric chaperone protease to degrade misfolded secretory proteins. Other human HtrA proteins have been implicated in arthritis, tumor suppression, unfolded stress response, apoptosis, and aging. [provided by RefSeq, Oct 2008]
Canonical amino-acid sequenceUniProt
476 residues, UniProt reviewed canonical sequence.
>P83105|HTRA4
1 MIRPQLRTAG LGRCLLPGLL LLLVPVLWAG AEKLHTQPSC PAVCQPTRCP ALPTCALGTT
61 PVFDLCRCCR VCPAAEREVC GGAQGQPCAP GLQCLQPLRP GFPSTCGCPT LGGAVCGSDR
121 RTYPSMCALR AENRAARRLG KVPAVPVQWG NCGDTGTRSA GPLRRNYNFI AAVVEKVAPS
181 VVHVQLWGRL LHGSRLVPVY SGSGFIVSED GLIITNAHVV RNQQWIEVVL QNGARYEAVV
241 KDIDLKLDLA VIKIESNAEL PVLMLGRSSD LRAGEFVVAL GSPFSLQNTA TAGIVSTKQR
301 GGKELGMKDS DMDYVQIDAT INYGNSGGPL VNLDGDVIGV NSLRVTDGIS FAIPSDRVRQ
361 FLAEYHEHQM KGKAFSNKKY LGLQMLSLTV PLSEELKMHY PDFPDVSSGV YVCKVVEGTA
421 AQSSGLRDHD VIVNINGKPI TTTTDVVKAL DSDSLSMAVL RGKDNLLLTV IPETINLocalizationUniProt · AlphaFold · HPA
Whether an antibody against HTRA4 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.33
- Highest tissue expression
- 63 nTPM
Expression across tissuesHPA
Tissue
- placenta: 63 nTPM
- bone marrow: 6.5 nTPM
- lymph node: 2.1 nTPM
- lung: 1.8 nTPM
- tonsil: 1.5 nTPM
- breast: 1 nTPM
Single-cell type
- extravillous trophoblasts: 813 nCPM
- syncytiotrophoblasts: 51 nCPM
- neutrophil progenitors: 19 nCPM
- thymocytes: 17 nCPM
- migrating cytotrophoblasts: 10 nCPM
- macrophages: 8.6 nCPM
Immune cell
- naive B-cell: 0.5 nTPM
- neutrophil: 0.5 nTPM
- eosinophil: 0.4 nTPM
- plasmacytoid DC: 0.4 nTPM
- basophil: 0.3 nTPM
- MAIT T-cell: 0.3 nTPM
Brain region
- cerebellum: 15 nTPM
- white matter: 14 nTPM
- medulla oblongata: 14 nTPM
- cerebral cortex: 13 nTPM
- hypothalamus: 13 nTPM
- thalamus: 13 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.34
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.97
- DepMap mean gene effect
- -0.02
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- negative regulation of transforming growth factor beta receptor signaling pathway
- positive regulation of apoptotic process
- programmed cell death
- proteolysis
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Insulin-like growth factor-binding protein, IGFBP
- PDZ domain
- Peptidase S1C
- Kazal domain
- Peptidase S1, PA clan
- Growth factor receptor cysteine-rich domain superfamily
- PDZ superfamily
- Kazal domain superfamily
- Insulin-like growth factor binding protein
- Kazal-type serine protease inhibitor domain
- PDZ domain
- Trypsin-like peptidase domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of HTRA4 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads HTRA4 as an antibody target. Whether an autoantibody or antibody against HTRA4 could matter depends on whether native HTRA4 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
HTRA4 is annotated as secreted, so native HTRA4 circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label HTRA4 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...